Metoprolol: here's the fair price
This is what US pharmacies pay, on average, for metoprolol. Use it to spot a fair cash price, and feel good about asking for one.
Metoprolol Tartrate 25 Mg Tab
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Metoprolol Tartrate 25 Mg Tab. Pharmacies pay about $0.48 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| METOPROLOL TARTRATE 25 MG TABGeneric | $0.02 per tablet or capsule | $0.48 | 10/21/2026 |
| METOPROLOL TARTRATE 50 MG TABGeneric | $0.02 per tablet or capsule | $0.61 | 10/21/2026 |
| METOPROLOL TARTRATE 100 MG TABGeneric | $0.03 per tablet or capsule | $0.88 | 10/21/2026 |
| METOPROLOL SUCC ER 50 MG TABGeneric | $0.05 per tablet or capsule | $1.48 | 10/21/2026 |
| METOPROLOL SUCC ER 25 MG TABGeneric | $0.05 per tablet or capsule | $1.59 | 10/21/2026 |
| METOPROLOL TARTRATE 37.5 MG TBGeneric | $0.08 per tablet or capsule | $2.27 | 10/21/2026 |
| METOPROLOL SUCC ER 100 MG TABGeneric | $0.08 per tablet or capsule | $2.52 | 10/21/2026 |
| METOPROLOL TARTRATE 75 MG TABGeneric | $0.15 per tablet or capsule | $4.62 | 10/21/2026 |
| METOPROLOL SUCC ER 200 MG TABGeneric | $0.18 per tablet or capsule | $5.42 | 10/21/2026 |
| METOPROLOL TARTRATE 12.5 MG TBGeneric | $2.84 per tablet or capsule | $85.31 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE Metoprolol tartrate tablet is a beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • Angina Pectoris. ( 1.2 ) • Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intravenous metoprolol therapy in patients with definite or suspected acute myocardial infarction in hemodynamically stable patients. ( 1.3 ) 1.1 Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension in adult patients, to lower blood...
Common side effects (FDA label)
6 ADVERSE REACTIONS The following adverse reactions are described elsewhere in labeling: Worsening angina or myocardial infarction [see Warnings and Precautions (5)] Worsening heart failure [see Warnings and Precautions (5)]. Worsening AV block [see Contraindications (4)]. • Most common adverse reactions: tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, rash. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Alembic Pharmaceuticals Limited at 1-866-210-9797 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience...
Drug interactions (from the label)
7 DRUG INTERACTIONS • Catecholamine-depleting drugs may have an additive effect when given with beta-blocking agents. ( 7.1 ) • Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. ( 7.2 ) • CYP2D6 Inhibitors are likely to increase metoprolol concentration. ( 7.3 ) • Concomitant use of glycosides, clonidine, and diltiazem and verapamil with beta-blockers can increase the risk of bradycardia. ( 7.4 ) • Beta-blockers including metoprolol, may exacerbate the rebound hypertension that can follow the withdrawal of clonidine. ( 7.4 ) 7.1 Catecholamine Depleting Drugs Catecholamine depleting drugs (e.g., reserpine, monoamine oxidase (MAO) inhibitors) may...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS • Abrupt cessation may exacerbate myocardial ischemia. ( 5.1 ) • Heart Failure: Worsening cardiac failure may occur. ( 5.2 ) • Bronchospastic Disease: Avoid beta-blockers. ( 5.3 ) • Pheochromocytoma: Initiate therapy with an alpha blocker. ( 5.4 ) • Major Surgery: Avoid initiation of high-dose extended-release metoprolol in patients undergoing non-cardiac surgery. Do not routinely withdraw chronic beta-blocker therapy prior to surgery. ( 5.5 , 6.1 ) • Diabetes: May mask symptoms of hypoglycemia. ( 5.6 ) • Thyrotoxicosis: Abrupt withdrawal in patients with thyrotoxicosis might precipitate a thyroid storm. ( 5.7 ) • Peripheral Vascular Disease: Can aggravate...
Source: FDA drug label via openFDA, label effective 2026-07-27. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.